RISK FACTORS OF DISTROPHIC DISEASES OF VULVAE: CLINICAL-EPIDEMIOLOGICAL RESEARCH


Cite item

Full Text

Abstract

The results of epidemiological studies of risk factors for the development of dystrophic diseases of the vulva (DDV) in women of reproductive and perimenopausal age are presented. Authors executed the testing of DDV patients according to specially developed questions of the questionnaire, aimed at the obtaining of the most complete information about the lifestyle of patients, social and medical factors, possibly contributing to the occurrence and formation of DDV. Also, the authors performed an examination of patients for the most common sexually transmitted infections (STIs), and urogenital infections in order to clarify the infectious factor in the genesis of dystrophy of the vulva. Direct and indirect factors that contribute to the formation of dystrophic diseases of the vulva in women are established to be as follows: perimenopausal age; endocrine diseases; emotional stress of a social character; more than 3 pregnancies in anamnesis; presence of STIs (herpes simplex virus, cytomegalovirus) and inflammatory diseases of the pelvic organs; presence of Candida fungi, Ureaplasma urealyticum bacteria, human papillomavirus - HPV 16/18, HPV 31/33 and some other infections on the background of DDV; lack of information about the disease; discharge from the genital tract; lack of treatment-effect; inappropriate treatment. The identified factors should be taken into account in the development of therapeutic and preventive measures in relation to DDV in women.

About the authors

Delya F. Porsokhonova

Republican specialized scientific and practical medical center of dermatology and venereology

Email: delya.porsokhonova@mail.ru
MD, PhD, DSci., senior researcher of the Republican specialized scientific and practical medical center of dermatology and venereology, Tashkent, 100109, Republic of Uzbekistan Tashkent, 100109, Republic of Uzbekistan

S. N Rakhmatullaeva

Republican specialized scientific and practical medical center of dermatology and venereology

Tashkent, 100109, Republic of Uzbekistan

A. I Yakubovich

Irkutsk State Medical University

Irkutsk, 664003, Russian Federation

V. S Novoselov

I.M.Sechenov First Moscow State Medical University

Moscow, 119991, Russian Federation

A. V Novoselov

I.M.Sechenov First Moscow State Medical University

Moscow, 119991, Russian Federation

V. A Kaptil’nyy

I.M.Sechenov First Moscow State Medical University

Moscow, 119991, Russian Federation

E. A Sosnova

I.M.Sechenov First Moscow State Medical University

Moscow, 119991, Russian Federation

References

  1. Кауфман Р., Фаро С., Браун Д. Доброкачественные заболевания вульвы и влагалища. М.; 2009: 320-43.
  2. Чулкова О.В., Новикова Е.Г., Соколов В.В., Чулкова Е.А. Диагностика и лечение фоновых и предраковых заболеваний вульвы. Практическая онкология. 2006; 7(4): 197-204.
  3. Кулаков В.И., Прилепская В.Н. (ред.). Практическая гинекология. 4-е изд. М.: «МЕДпресс-информ»; 2008: 69-74.
  4. Ашрафян Л.А., Харченко Н.В., Киселёв В.И. и др. Рак вульвы: этиопатогенетическая концепция. М.; 2006.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Eco-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).